FibroBiologics has filed with the U.S. Securities and Exchange Commission to raise $8,000,000.00 in an Initial Public Offering
According to filings with the U.S. Securities and Exchange Commission, FibroBiologics is raising $8,000,000.00 in new funding. About FibroBiologics: Our proprietary fibroblast platform serves as the foundation for developing biologic cures and treatments for chronic…